These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 31057544)

  • 1. Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools.
    Ben Mkaddem S; Benhamou M; Monteiro RC
    Front Immunol; 2019; 10():811. PubMed ID: 31057544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fc-receptors as regulators of immunity.
    Nimmerjahn F; Ravetch JV
    Adv Immunol; 2007; 96():179-204. PubMed ID: 17981207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Fc receptor in autoimmune disease.
    Li X; Kimberly RP
    Expert Opin Ther Targets; 2014 Mar; 18(3):335-50. PubMed ID: 24521454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory ITAM signaling by Fc alpha RI-FcR gamma chain controls multiple activating responses and prevents renal inflammation.
    Kanamaru Y; Pfirsch S; Aloulou M; Vrtovsnik F; Essig M; Loirat C; Deschênes G; Guérin-Marchand C; Blank U; Monteiro RC
    J Immunol; 2008 Feb; 180(4):2669-78. PubMed ID: 18250479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of Fc receptors on the development of autoimmune diseases.
    Kleinau S
    Curr Pharm Des; 2003; 9(23):1861-70. PubMed ID: 12871190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory ITAMs as novel regulators of immunity.
    Blank U; Launay P; Benhamou M; Monteiro RC
    Immunol Rev; 2009 Nov; 232(1):59-71. PubMed ID: 19909356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prospects for targeting FcR as a novel therapeutic strategy in rheumatoid arthritis.
    Wu Y; Pan W; Hu X; Zhang A; Wei W
    Biochem Pharmacol; 2021 Jan; 183():114360. PubMed ID: 33301760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative signaling in Fc receptor complexes.
    Daëron M; Lesourne R
    Adv Immunol; 2006; 89():39-86. PubMed ID: 16682272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fc receptors act as innate immune receptors during infection?
    Laassili C; Ben El Hend F; Benzidane R; Oumeslakht L; Aziz AI; El Fatimy R; Bensussan A; Ben Mkaddem S
    Front Immunol; 2023; 14():1188497. PubMed ID: 37564652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fc receptor targeting in the treatment of allergy, autoimmune diseases and cancer.
    Nakamura A; Kubo T; Takai T
    Adv Exp Med Biol; 2008; 640():220-33. PubMed ID: 19065795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives.
    Ben Mkaddem S; Rossato E; Heming N; Monteiro RC
    Autoimmun Rev; 2013 Apr; 12(6):666-9. PubMed ID: 23201915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fc receptors gone wrong: A comprehensive review of their roles in autoimmune and inflammatory diseases.
    Chalayer E; Gramont B; Zekre F; Goguyer-Deschaumes R; Waeckel L; Grange L; Paul S; Chung AW; Killian M
    Autoimmun Rev; 2022 Mar; 21(3):103016. PubMed ID: 34915182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fc receptors and their role in immune regulation and autoimmunity.
    Takai T
    J Clin Immunol; 2005 Jan; 25(1):1-18. PubMed ID: 15742153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-talk between pathogen recognizing Toll-like receptors and immunoglobulin Fc receptors in immunity.
    van Egmond M; Vidarsson G; Bakema JE
    Immunol Rev; 2015 Nov; 268(1):311-27. PubMed ID: 26497530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs.
    Fiebiger BM; Maamary J; Pincetic A; Ravetch JV
    Proc Natl Acad Sci U S A; 2015 May; 112(18):E2385-94. PubMed ID: 25870292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translating Inhibitory Fc Receptor Biology into Novel Therapeutic Approaches.
    Nimmerjahn F
    J Clin Immunol; 2016 May; 36 Suppl 1():83-7. PubMed ID: 26957094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory ITAM signaling traps activating receptors with the phosphatase SHP-1 to form polarized "inhibisome" clusters.
    Pfirsch-Maisonnas S; Aloulou M; Xu T; Claver J; Kanamaru Y; Tiwari M; Launay P; Monteiro RC; Blank U
    Sci Signal; 2011 Apr; 4(169):ra24. PubMed ID: 21505186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation.
    Braselmann S; Taylor V; Zhao H; Wang S; Sylvain C; Baluom M; Qu K; Herlaar E; Lau A; Young C; Wong BR; Lovell S; Sun T; Park G; Argade A; Jurcevic S; Pine P; Singh R; Grossbard EB; Payan DG; Masuda ES
    J Pharmacol Exp Ther; 2006 Dec; 319(3):998-1008. PubMed ID: 16946104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Fc receptors and complement in autoimmunity.
    Mihai S; Nimmerjahn F
    Autoimmun Rev; 2013 Apr; 12(6):657-60. PubMed ID: 23201918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inside-Out Control of Fc-Receptors.
    Koenderman L
    Front Immunol; 2019; 10():544. PubMed ID: 30949181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.